Vidac Pharma has secured €600,000 ($645,651) in additional funding to support the clinical development of its two lead cancer candidates. The funding from existing investors, announced at the ...

Topical cream is a standard treatment for basal cell carcinoma, the most common type of skin cancer worldwide. If your healthcare provider has prescribed the topical medication Efudex ...

Vidac will use the new funds to initiate a Phase IIb trial of its lead candidate VDA-1102 in patients with actinic keratosis.

The skin cancer gel developer Peplin has said that it would speed up the process of human testing of its fast-action cancer cream since it was able to get an amount of $10 million from ...

A new analysis has once again found that dozens of popular acne creams and cleansers contain “unacceptably high levels” of a cancer-causing chemical. Professors from Yale and Long Island ...